{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T19:27:23Z","timestamp":1770146843371,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T00:00:00Z","timestamp":1563753600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ijrobp.2019.07.022","type":"journal-article","created":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T11:31:41Z","timestamp":1563881501000},"page":"884-892","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Compartmental Model for 223Ra-Dichloride in Patients With Metastatic Bone Disease From Castration-Resistant Prostate Cancer"],"prefix":"10.1016","volume":"105","author":[{"given":"Jan","family":"Taprogge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iain","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Gear","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah J.","family":"Chittenden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher C.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn D.","family":"Flux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2019.07.022_bib1","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ejca.2011.12.023","article-title":"A randomized, dose-response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer","volume":"48","author":"Nilsson","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2019.07.022_bib2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJMoa1213755","article-title":"Alpha emitter radium-223 and survival in metastatic prostate cancer","volume":"369","author":"Parker","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2019.07.022_bib3","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S1470-2045(18)30860-X","article-title":"Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): A randomised, double-blind, placebo-controlled, phase 3 trial","volume":"20","author":"Smith","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2019.07.022_bib4","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.ijrobp.2014.12.061","article-title":"Radium-223 in the treatment of osteoblastic metastases: A critical clinical review","volume":"91","author":"Humm","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.07.022_bib5","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0140-6736(14)61947-4","article-title":"Prostate cancer","volume":"387","author":"Attard","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2019.07.022_bib6","first-page":"249","article-title":"Dosage and response in radiopharmaceutical therapy of painful osseous metastases","volume":"37","author":"Silberstein","year":"1996","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2019.07.022_bib7","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/266653a0","article-title":"High-LET radiations induce a large proportion of nonrejoining DNA breaks","volume":"266","author":"Ritter","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.ijrobp.2019.07.022_bib8","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1007\/s00259-016-3386-5","article-title":"Radium-223 dichloride in clinical practice: A review","volume":"43","author":"Florimonte","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ijrobp.2019.07.022_bib9","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S1470-2045(14)70474-7","volume":"15","author":"Hoskin","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2019.07.022_bib10","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S1470-2045(14)70183-4","article-title":"Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: Results from a phase 3, double-blind, randomised trial","volume":"15","author":"Sartor","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2019.07.022_bib11","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/annonc\/mdw065","article-title":"Patient-reported quality-of-life analysis of radium-223 dichloride from the phase III ALSYMPCA study","volume":"27","author":"Nilsson","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2019.07.022_bib12","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1007\/s00259-013-2427-6","article-title":"Phase I pharmacokinetic and biodistribution study with escalating doses of 223Ra-dichloride in men with castration-resistant metastatic prostate cancer","volume":"40","author":"Carrasquillo","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ijrobp.2019.07.022_bib13","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.2967\/jnumed.115.157123","article-title":"A Phase 1, Open-Label Study of the Biodistribution, Pharmacokinetics, and Dosimetry of 223Ra-Dichloride in Patients with Hormone-Refractory Prostate Cancer and Skeletal Metastases","volume":"56","author":"Chittenden","year":"2015","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2019.07.022_bib14","first-page":"3120","article-title":"Significant antitumor effect from bone-seeking, alpha-particle-emitting (223)Ra demonstrated in an experimental skeletal metastases model","volume":"62","author":"Henriksen","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2019.07.022_bib15","first-page":"252","article-title":"Targeting of osseous sites with alpha-emitting 223Ra: Comparison with the beta-emitter 89Sr in mice","volume":"44","author":"Henriksen","year":"2003","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2019.07.022_bib16","doi-asserted-by":"crossref","first-page":"djv380","DOI":"10.1093\/jnci\/djv380","article-title":"Whole-body and microenvironmental localization of radium-223 in naive and mouse models of prostate cancer metastasis","volume":"108","author":"Abou","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2019.07.022_bib17","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1158\/1078-0432.CCR-16-2955","article-title":"Radium-223 inhibits osseous prostate cancer growth by dual targeting of cancer cells and bone microenvironment in mouse models","volume":"23","author":"Suominen","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2019.07.022_bib18","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1093\/jnci\/djt116","article-title":"Survival benefit with radium-223 dichloride in a mouse model of breast cancer bone metastasis","volume":"105","author":"Suominen","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2019.07.022_bib19","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ctrv.2012.03.006","article-title":"Targeted radio-nuclide therapy of skeletal metastases","volume":"39","author":"Sartor","year":"2013","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ijrobp.2019.07.022_bib20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/oxfordjournals.rpd.a081254","article-title":"A generic age-specific biokinetic model for calcium-like elements","volume":"41","author":"Leggett","year":"1992","journal-title":"Radiat Prot Dosimetry"},{"key":"10.1016\/j.ijrobp.2019.07.022_bib21","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1088\/0031-9155\/57\/10\/3207","article-title":"A bone marrow toxicity model for 223Ra alpha-emitter radiopharmaceutical therapy","volume":"57","author":"Hobbs","year":"2012","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ijrobp.2019.07.022_bib22","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.ijrobp.2018.12.015","article-title":"Mechanistic modeling of radium-223 treatment of bone metastases","volume":"103","author":"Moreira","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.07.022_bib23","first-page":"95","article-title":"Age-dependent doses to members of the public from intake of radionuclides - Part 2 ingestion dose coefficients: ICRP Publication 67","volume":"23","year":"1993","journal-title":"Ann ICRP"},{"key":"10.1016\/j.ijrobp.2019.07.022_bib24","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00004032-200401000-00007","article-title":"Biokinetic model of radium in humans and beagles","volume":"86","author":"Polig","year":"2004","journal-title":"Health Phys"},{"key":"10.1016\/j.ijrobp.2019.07.022_bib25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00259-012-2265-y","article-title":"Dosimetry of 223Ra-chloride: Dose to normal organs and tissues","volume":"40","author":"Lassmann","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ijrobp.2019.07.022_bib26","first-page":"243","article-title":"Optimization of Equipment and Methodology for Whole Body Activity Retention Measurements in Children Undergoing Targeted Radionuclide Therapy","volume":"22","author":"Chittenden","year":"2007","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.ijrobp.2019.07.022_bib27","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1007\/s00259-010-1422-4","article-title":"EANM Dosimetry Committee guidelines for bone marrow and whole-body dosimetry","volume":"37","author":"Hindorf","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ijrobp.2019.07.022_bib28","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1097\/MNM.0b013e328353bb6e","article-title":"Quantitative imaging of 223Ra-chloride (Alpharadin) for targeted alpha-emitting radionuclide therapy of bone metastases","volume":"33","author":"Hindorf","year":"2012","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.ijrobp.2019.07.022_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0146-6453(00)80004-4","article-title":"Basic anatomical and physiological data for use in radiological protection: The skeleton: ICRP Publication 70","volume":"25","year":"1995","journal-title":"Ann ICRP"},{"key":"10.1016\/j.ijrobp.2019.07.022_bib30","first-page":"1","article-title":"Basic anatomical and physiological data for use in radiological protection: Reference values: ICRP Publication 89","volume":"32","year":"2002","journal-title":"Ann ICRP"},{"key":"10.1016\/j.ijrobp.2019.07.022_bib31","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0026-0495(98)90064-6","article-title":"SAAM II: Simulation, analysis, and modeling software for tracer and pharmacokinetic studies","volume":"47","author":"Barrett","year":"1998","journal-title":"Metabolism"},{"key":"10.1016\/j.ijrobp.2019.07.022_bib32","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1161\/01.ATV.18.6.853","article-title":"Development of compartmental models in stable-isotope experiments","volume":"18","author":"Pont","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ijrobp.2019.07.022_bib33","series-title":"Mathematical Modeling in Experimental Nutrition","article-title":"Developing and Testing Integrated Multicompartment Models to Describe a Single-Input Multiple-Output Study Using the SAAM II Software System","author":"Foster","year":"1998"},{"key":"10.1016\/j.ijrobp.2019.07.022_bib34","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1109\/TAC.1974.1100705","article-title":"A new look at the statistical model identification","volume":"19","author":"Akaike","year":"1974","journal-title":"IEEE Trans Automat Contr"},{"key":"10.1016\/j.ijrobp.2019.07.022_bib36","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s12149-016-1093-8","article-title":"Pharmacokinetics of single dose radium-223 dichloride (BAY 88-8223) in Japanese patients with castration-resistant prostate cancer and bone metastases","volume":"30","author":"Yoshida","year":"2016","journal-title":"Ann Nucl Med"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301619335059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301619335059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:45:20Z","timestamp":1759743920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301619335059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0360301619335059"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2019.07.022","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Compartmental Model for 223Ra-Dichloride in Patients With Metastatic Bone Disease From Castration-Resistant Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2019.07.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}